ALDEYRA THERAPEUTICS INC (ALDX)
US01438T1060 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 17.56M | 128.51M | 135.20M | 100.40M | 23.50M | |||
| Cash Equivalents | 84.93M | 14.31M | 9.30M | 129.40M | 54.40M | |||
| Marketable Securities | 30.55M | 0.00 | 29.90M | 0.00 | N/A | |||
| Other Current Assets | 7.81M | 4.99M | 6.70M | 3.00M | 5.20M | |||
| Total Current Assets | 140.85M | 147.81M | 181.00M | 232.80M | 83.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 455.95K | 516.58K | 300.00K | 400.00K | 300.00K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | N/A | |||
| Total Non-Current Assets | 455.94K | 516.58K | 300.00K | 300.00K | 300.00K | |||
| TOTAL ASSETS | 141.30M | 148.33M | 181.30M | 233.10M | 83.40M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 15.20M | 15.15M | 900.00K | 0.00 | 3.70M | |||
| Accrued Expenses | 6.19M | 5.78M | 14.30M | 10.80M | 8.40M | |||
| Accounts Payable | 280.30K | 1.34M | 100.00K | 1.00M | 400.00K | |||
| Total Current Liabilities | 21.68M | 22.26M | 15.40M | 11.80M | 12.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 14.90M | 15.50M | 11.40M | |||
| Other Non-Current Liabilities | 6.21M | 6.27M | 0.00 | 100.00K | N/A | |||
| Total Non-Current Liabilities | 6.21M | 6.27M | 14.90M | 15.60M | 11.40M | |||
| TOTAL LIABILITIES | 27.88M | 28.53M | 30.30M | 27.40M | 23.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -402.34M | -394.26M | -356.70M | -294.70M | -236.90M | |||
| Additional Paid In Capital | 515.70M | 513.99M | 507.80M | 500.40M | 296.40M | |||
| Common Shares | 59.42K | 59.20K | 100.00K | 100.00K | 0.00 | |||
| Other Shareholders' Equity | -3.03K | 0.00 | -100.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 59.41M | 59.20M | 58.60M | 58.10M | 38.70M | |||
| Tangible Book Value per Share | 1.91 | 2.02 | 2.58 | 3.54 | 1.54 | |||
| Total Shareholders' Equity | 113.42M | 119.80M | 151.00M | 205.70M | 59.50M | |||
| TOTAL LIABILITIES AND EQUITY | 141.30M | 148.33M | 181.30M | 233.10M | 83.40M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.10 | 0.08 | 0.19 | |||
| Current Ratio | 6.50 | 6.64 | 11.75 | 19.73 | 6.70 | |||
| Return On Assets (ROA) | -21.24% | -25.31% | -34.21% | -24.79% | -45.02% | |||
| Return On Equity (ROE) | -26.46% | -31.34% | -41.07% | -28.09% | -63.11% | |||
All data in USD